BUZZ-GeneDx rises after Q3 results beat market estimates

Reuters10-29

Updates

** Genetic testing company GeneDx's WGS.O shares rise 11% to $145.51, hitting highest level in over three years

** Co posts Q3 revenue of $116.7 mln, above analysts' estimates of $104.1 mln

** Co's adj EPS for Q3 also beats estimates

** WGS raises full-year 2025 revenue forecast to $425 mln-$428 mln vs earlier forecast of $400 mln-$415 mln

** Eight out of 9 analysts rate stock "buy" or higher, one "hold"; median PT is $125

** As of last close, WGS was up 70% YTD

(Reporting by Tharuniyaa Lakshmi in Bengaluru)

((tharuniyaa@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2579998426?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-29 02:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579998426","market":"fut","top_or_hot":-1,"title":"BUZZ-GeneDx rises after Q3 results beat market estimates","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-GeneDx rises after Q3 results beat market estimates</title></head><body><p>Updates</p><p>** Genetic testing company GeneDx's <span>WGS.O</span> shares rise 1<span>1</span>% to $1<span>45.51, hitting highest level in over three years</span></p><p>** Co posts Q3 reve<span>nue</span> of $116.7 mln, above analysts' estimates of $104.1 mln</p><p>** Co's adj EPS for Q3 also beats estimates</p><p>** WGS raises full-year 2025 revenue forecast to $425 <span>mln</span>-$428 mln vs earlier forecast of $400 <span>mln</span>-$415 mln</p><p>** Eight out of 9 analysts rate stock \"buy\" or higher, one \"hold\"; median PT is $125</p><p>** As of last close, WGS <span>was up </span>70% YTD</p><p> (Reporting by Tharuniyaa Lakshmi in Bengaluru)</p><p> ((tharuniyaa@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-GeneDx rises after Q3 results beat market estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-GeneDx rises after Q3 results beat market estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-29 02:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-GeneDx rises after Q3 results beat market estimates</title></head><body><p>Updates</p><p>** Genetic testing company GeneDx's <span>WGS.O</span> shares rise 1<span>1</span>% to $1<span>45.51, hitting highest level in over three years</span></p><p>** Co posts Q3 reve<span>nue</span> of $116.7 mln, above analysts' estimates of $104.1 mln</p><p>** Co's adj EPS for Q3 also beats estimates</p><p>** WGS raises full-year 2025 revenue forecast to $425 <span>mln</span>-$428 mln vs earlier forecast of $400 <span>mln</span>-$415 mln</p><p>** Eight out of 9 analysts rate stock \"buy\" or higher, one \"hold\"; median PT is $125</p><p>** As of last close, WGS <span>was up </span>70% YTD</p><p> (Reporting by Tharuniyaa Lakshmi in Bengaluru)</p><p> ((tharuniyaa@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WGS","symbol_name":"GeneDx Holdings","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nL4N3W929K:1","article_id":"2579998426","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579998426","pubTimestamp":1761675615,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-GeneDx rises after Q3 results beat market estimatesUpdates** Genetic testing company GeneDx's WGS.O shares rise 11% to $145.51, hitting highest level in over three years** Co posts Q3 revenue of $116.7 mln, above analysts' estimates of $104.1 mln** Co's adj EPS for Q3 also beats estimates** WGS raises full-year 2025 revenue forecast to $425 mln-$428 mln vs earlier forecast of $400 mln-$415 mln** Eight out of 9 analysts rate stock \"buy\" or higher, one \"hold\"; median PT is $125** As of last close, WGS was up 70% YTD  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WGS":"GeneDx Holdings","BK4196":"保健护理服务"},"translate_title":"BUZZ-GeneDx第三季度业绩超出市场预期后股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WGS":0.9},"content_text":"BUZZ-GeneDx rises after Q3 results beat market estimatesUpdates** Genetic testing company GeneDx's WGS.O shares rise 11% to $145.51, hitting highest level in over three years** Co posts Q3 revenue of $116.7 mln, above analysts' estimates of $104.1 mln** Co's adj EPS for Q3 also beats estimates** WGS raises full-year 2025 revenue forecast to $425 mln-$428 mln vs earlier forecast of $400 mln-$415 mln** Eight out of 9 analysts rate stock \"buy\" or higher, one \"hold\"; median PT is $125** As of last close, WGS was up 70% YTD (Reporting by Tharuniyaa Lakshmi in Bengaluru) ((tharuniyaa@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2579998426","isCrawlerRequest":true}